2016 Annual Meeting

International Society of Breast Pathology

Room CC Hall 4 E, March 13 2016, 7:30pm to 10:30pm


International Society of Breast Pathology
Second Opinions and Diagnostic Concordance in Breast Pathology
Sunday, March 13, 2016

Credits: 3 CME and 3 SAMs

Moderators: Aysegul Sahin, MD, The University of Texas MD Anderson Cancer Center, Houston, and Gelareh Farshid, MD, The University of Adelaide, Australia

An accurate diagnosis/classification of breast lesions is essential to ensure that the patients receive the most effective treatment. Many Breast Cancer Advocacy groups have recommended that every patient with diagnosis of breast cancer should obtain second opinion on both diagnosis/pathology and on treatment choices. Obtaining second opinions is an established part of pathology practice, and many healthcare institutions have implemented policies requiring them. Many hospitals in the United States mandate a second review of pathology slides from outside laboratories before surgical interventions or for all cancer diagnoses before treatment planning. Second opinions may also be important for high-risk non-malignant borderline breast lesions, which have greater diagnostic disagreement than malignant lesions, to assure that cancer is not misdiagnosed and assess patient risk for development of breast cancer to guide surveillance and risk reduction strategies. Although second opinions may improve diagnostic accuracy and the quality of patient care, as well as provide opportunities to educate physicians, policies and practices for obtaining second opinions are not well established. In this session a multidisciplinary panel of breast cancer experts will discuss importance and impact of pathology second opinions in breast cancer management. The purpose of the companion meeting is to inform the audience regarding the most recent changes in the practice of breast pathology. The current program will cover assessment of diagnostic accuracy of breast pathology and significance of second opinions in breast pathology.

Upon completion of this educational activity, participants should be better able to:

  1. Discuss the clinical importance of prognostic and predictive factors in the classification of breast cancer and understand the technical issues that may cause diagnostic difficulty.
  2. Evaluate and articulate the responsibility of the pathologists to provide second opinions.
  3. Identify common entities that may have borderline histopathology findings and subjective evaluations that may cause diagnostic discrepancies among different pathologists.
  4. Summarize the clinical uses and limitations of second opinion in breast pathology.

7:00 PM

Business Meeting

7:20 PM

Introduction and President's Remarks
Ira Bleiweiss, MD, Mount Sinai Hospital, New York, NY

7:20 PM

Presentation of Trainee Awards
Puay Hoon Tan, MD, Singapore General Hospital, Singapore

7:30 PM

How Good are You at Breast Pathology? Lessons from the UK EQA Program
Ian O. Ellis, MD, University of Nottingham, Nottingham, England

8:00 PM

Breast Cancer Diagnosis and Surgical Pathology A Critical Global Oncology Issue
Benjamin O. Anderson, MD, University of Washington, Seattle, WA

8:30 PM

Discrepant Diagnoses Where's the Harm?
Jean F. Simpson, MD, Breast Pathology Consultants, Nashville, TN

9:00 PM

How Ancillary Techniques May Be Utilized to Improve Diagnostic Accuracy in Breast Pathology
Allen M. Gown, MD, PhenoPath Laboratories, Seattle, WA

9:30 PM

Questions & Answers


view more